Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

“Both in kids and adults, we just don’t know. These meds are new enough that we need more time,” Straughn said. Wegovy, which is the weight-loss equivalent to the drug Ozempic, is approved ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Ozempic was first approved by the FDA in 2017 for blood sugar control in Type 2 diabetes. It received a cardiovascular indication in 2020 and is now the most broadly indicated GLP-1 receptor agonist ...

Our editors also may be in touch with follow-up questions. Ozempic is a brand-name, injectable semaglutide medication. It’s prescribed, alongside dietary changes and exercise, to adults with ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

“Ozempic personality” refers more to a slew of symptoms form taking the drug, including irritability, depression, anxiety, feeling emotionally flat or having low energy. This has often led to ...

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...